Ten_CD Largest_NNP Investments_NNP continued_VBD 30_CD September_NNP 2002_CD Roche_NNP 3.4_CD %_NN of_IN portfolio_NN ,_, the_DT Swiss_JJ pharmaceutical_JJ group_NN ,_, has_VBZ seen_VBN its_PRP$ share_NN price_NN outperform_VBP the_DT stock_NN market_NN significantly_RB during_IN the_DT period_NN ._.
Recent_JJ management_NN changes_NNS and_CC a_DT restructuring_NN program_NN should_MD lead_VB to_TO rising_VBG margins_NNS over_IN the_DT next_JJ three_CD years_NNS ._.
Some_DT concerns_NNS remain_VBP regarding_VBG sales_NNS growth_NN and_CC newsflow_NN on_IN drug_NN development_NN will_MD be_VB a_DT key_JJ driver_NN of_IN the_DT share_NN price_NN ._.
The_DT companys_NNS existing_VBG franchise_NN in_IN the_DT oncology_NN market_NN cancer_NN treatment_NN drugs_NNS such_JJ as_IN Retaxin_NNP is_VBZ strong_JJ ,_, however_RB ,_, and_CC the_DT shares_NNS are_VBP attractively_RB valued_VBN compared_VBN to_TO peers_NNS ._.
UniCredito_NNP Italiano_NNP 2.7_CD %_NN of_IN portfolio_NN ,_, the_DT Italian_JJ retail_JJ bank_NN ,_, has_VBZ delivered_VBN a_DT solid_JJ share_NN price_NN performance_NN relative_JJ to_TO the_DT market_NN during_IN the_DT period_NN ._.
The_DT company_NN is_VBZ well_RB managed_VBN ,_, benefiting_VBG from_IN being_VBG based_VBN in_IN the_DT more_RBR prosperous_JJ northern_JJ part_NN of_IN Italy_NNP ,_, and_CC is_VBZ leading_VBG consolidation_NN in_IN the_DT Italian_JJ banking_NN sector_NN ._.
The_DT recent_JJ acquisition_NN of_IN the_DT minorities_NNS in_IN Rolo_NNP Banca_NNP should_MD lead_VB to_TO further_JJ efficiency_NN gains_NNS as_IN full_JJ control_NN of_IN operations_NNS is_VBZ established_VBN ._.
Going_VBG forward_RB ,_, much_RB will_MD depend_VB on_IN the_DT performance_NN of_IN the_DT overall_JJ economy_NN ,_, and_CC in_IN particular_JJ the_DT quality_NN of_IN their_PRP$ loan_NN book_NN ._.
Telefonica_NNP 2.5_CD %_NN of_IN portfolio_NN ,_, the_DT Spanish_JJ telecoms_NNS operator_NN ,_, delivered_VBD a_DT disappointing_JJ share_NN price_NN performance_NN during_IN the_DT period_NN ,_, as_IN concerns_NNS about_IN Latin_JJ American_JJ investments_NNS increased_VBD ._.
At_IN the_DT current_JJ valuation_NN ,_, we_PRP believe_VBP that_IN these_DT concerns_NNS are_VBP overdone_VBN ,_, and_CC are_VBP encouraged_VBN by_IN the_DT companys_NNS withdrawal_NN from_IN onerous_JJ capital_NN expenditure_NN commitments_NNS in_IN Germany_NNP ._.
In_IN Spain_NNP ,_, Telefonica_NNP retains_VBZ its_PRP$ dominant_JJ market_NN position_NN in_IN the_DT provision_NN of_IN both_DT fixed_VBN and_CC mobile_JJ telecoms_NNS services_NNS ._.
Cash_NN generation_NN is_VBZ strong_JJ and_CC the_DT balance_NN sheet_NN looks_VBZ robust_JJ ._.
However_RB ,_, uncertainty_NN over_IN Latin_NNP America_NNP may_MD prevent_VB the_DT share_NN price_NN from_IN rallying_VBG in_IN the_DT short-term_JJ ._.
E._NNP On_IN 2.4_CD %_NN of_IN portfolio_NN ,_, the_DT German_JJ utility_NN company_NN ,_, continued_VBD its_PRP$ strategy_NN of_IN refocusing_VBG on_IN the_DT core_NN electricity_NN and_CC gas_NN business_NN ._.
The_DT share_NN price_NN performance_NN over_IN the_DT past_JJ six_CD months_NNS has_VBZ reflected_VBN the_DT markets_NNS growing_VBG confidence_NN in_IN this_DT strategy_NN ,_, as_RB well_RB as_IN the_DT security_NN of_IN the_DT companys_NNS earnings_NNS ,_, despite_IN weak_JJ economic_JJ growth_NN ._.
With_IN German_JJ electricity_NN prices_NNS rising_VBG ,_, the_DT core_NN business_NN is_VBZ performing_VBG better_JJR than_IN expected_VBN ._.
Reinvestment_NNP risks_NNS regarding_VBG future_JJ acquisitions_NNS remains_VBZ a_DT key_JJ concern_NN for_IN investors_NNS ,_, but_CC are_VBP more_RBR than_IN reflected_VBN in_IN the_DT current_JJ share_NN price_NN ._.
Aventis_NNP 2.3_CD %_NN of_IN portfolio_NN ,_, the_DT French_JJ pharmaceutical_JJ company_NN ,_, has_VBZ seen_VBN its_PRP$ share_NN price_NN perform_VB well_RB relative_JJ to_TO the_DT market_NN ._.
The_DT sale_NN of_IN the_DT agro-chemical_JJ business_NN to_TO Bayer_NNP should_MD allow_VB the_DT management_NN to_TO focus_VB on_IN growing_VBG Aventis_NNP core_NN business_NN ._.
The_DT restructuring_NN implemented_VBD over_IN the_DT past_JJ two_CD years_NNS is_VBZ bearing_VBG fruits_NNS on_IN both_DT revenues_NNS and_CC earnings_NNS ._.
The_DT shares_NNS look_VBP attractively_RB valued_VBN and_CC concerns_NNS surrounding_VBG the_DT competitive_JJ threat_NN to_TO Allegra_NNP ,_, an_DT anti-histamine_JJ ,_, are_VBP most_RBS likely_JJ overdone_VBN ._.
